Notably, treatment with the PYCR1 inhibitor, PYCR1-IN-1, suppressed EGFR-driven 3D tumor spheroid formation, further demonstrating the functional relevance of PYCR1 in EGFR signaling. Here, EGFR is linked to neoplasm.